Cigna Corporation (CI – Q3FY20) – Evernorth segment leading the quarter performance.

in , on January 12, 2021

U.S. Medical Segment adjusted revenues increased by 5% to $9.63bn in Q3FY20 which reflects customer growth in U.S. Commercial insured and Medicare Advantage businesses, as well as higher premium rates due to anticipated underlying medical cost trend and the resumption of the health insurance industry tax.

Executive Summary

Financial Statements

– Income Statement and Forecast
– Balance Sheet
– Cash Flow
– Q3FY20 – Results Overview
– Segment Performance
– Q3FY20 – Customer Relationships
– Q3FY20 – Developments
– FY20 – Guidance
– Conclusion
– GAAP to Non-GAAP Reconciliation

Historical Performance

– Key Ratios
– Profitability Ratios, Asset Turnover Ratio, Growth Ratio
– Per Share Items and Key Ratios
– Key Balance Sheet and Cash Flow Items
– P/E band

Product Performance and Key Developments

– Ownership
– Competitors
– Key Developments

Valuation and Consensus Performance

– Relative Valuation
– Analyst Recommendations

Market Price Performance

CrispIdea Coverage

No of Pages : 50

Release Information

  • Released
    :

    January 12, 2021

  • Last Updated
    :

    January 12, 2021